• Exchange: Venture
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Cynapsus Therapeutics Inc

+ Add to Watchlist

CTH:CN

0.5600 CAD 0.0400 6.67%

As of 15:59:31 ET on 04/17/2014.

Snapshot for Cynapsus Therapeutics Inc (CTH)

Open: 0.6100 Day's Range: 0.5600 - 0.6350 Volume: 1,622,566
Previous Close: 0.6000 52wk Range: 0.2700 - 1.5100 1-Yr Rtn: +51.35%

Stock Chart for CTH

No chart data available.
  • CTH:CN 0.5600
  • 1D
  • 1M
  • 1Y
0.6000
Interactive CTH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CTH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.1700
Est. EPS (CAD) (12/2014) -
Est. PEG Ratio -
Market Cap (M CAD) 22.48
Shares Outstanding (M) 40.14
30 Day Average Volume 540,179
Price/Book (mrq) 9.1612
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/23/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CTH

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for CTH

Cynapsus Therapeutics, Inc. researches and develops pharmaceuticals. The Company researches treatments for Parkinson's disease, neuropathic pain associated with multiple sclerosis and cancer, and nausea and vomiting and appetite stimulation.

Anthony J GiovinazzoPresident/CEOAndrew Michael WilliamsCFO/COO
More Company Profile & Key Executives for CTH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil